<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.18082</field>
		<field name="filename">24922_okamotookubo_ce_me_bot_par.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
RESSALVA 

Atendendo solicitação do(a) 
autor(a), o texto completo desta tese 
será disponibilizado somente a partir 

de 23/05/2018. 



UNIVERSIDADE ESTADUAL PAULISTA 

“JÚLIO DE MESQUITA FILHO” 

Campus de Botucatu  

Faculdade de Medicina Veterinária e Zootecnia 

EFEITO ANALGÉSICO DO PLASMA RICO EM PLAQUETAS E CÉLULAS-

TRONCO NA DOR CRÔNICA DE CÃES COM DISPLASIA COXOFEMORAL 

CELINA EMIKO OKAMOTO OKUBO 

BOTUCATU – SP 

Maio 2016



UNIVERSIDADE ESTADUAL PAULISTA 

“JÚLIO DE MESQUITA FILHO” 

Campus de Botucatu  

Faculdade de Medicina Veterinária e Zootecnia 

EFEITO ANALGÉSICO DO PLASMA RICO EM PLAQUETAS E CÉLULAS-

TRONCO NA DOR CRÔNICA DE CÃES COM DISPLASIA COXOFEMORAL 

CELINA EMIKO OKAMOTO OKUBO 

Tese apresentada à Faculdade de 
Medicina Veterinária e Zootecnia, 
Universidade Estadual Paulista “Júlio 
de Mesquita Filho”, Campus de 
Botucatu, para obtenção do título de 
mestre na área de Biotecnologia 
animal.  

Orientador: Prof. Titular Stelio Pacca Loureiro Luna 

Co-orientadora: Profa. Titular Fernanda da Cruz Landim 

BOTUCATU – SP 

Maio  2016





UNIVERSIDADE ESTADUAL PAULISTA 

“JÚLIO DE MESQUITA FILHO” 

Campus de Botucatu  

Faculdade de Medicina Veterinária e Zootecnia 

EFEITO ANALGÉSICO DO PLASMA RICO EM PLAQUETAS E CÉLULAS-

TRONCO NA DOR CRÔNICA DE CÃES COM DISPLASIA COXOFEMORAL 

Celina Emiko Okamoto Okubo 

Candidata 

Prof. Titular Stelio Pacca Loureiro Luna 

Orientador 

Profa. Titular Fernanda da Cruz Landim 

Co-orientadora 

BOTUCATU – SP 

Maio  2016



UNIVERSIDADE ESTADUAL PAULISTA 

“JÚLIO DE MESQUITA FILHO” 

Campus de Botucatu  

Faculdade de Medicina Veterinária e Zootecnia 

EFEITO ANALGÉSICO DO PLASMA RICO EM PLAQUETAS E CÉLULAS-

TRONCO NA DOR CRÔNICA DE CÃES COM DISPLASIA COXOFEMORAL 

Programa de Pós-Graduação em Biotecnologia Animal 

Área de Cirurgia e Anestesiologia Veterinária 

Pós Graduanda:  

Celina Emiko Okamoto Okubo (Depto. Cirurgia e Anestesiologia Veterinária-FMVZ/ 

UNESP/ Botucatu) 

Orientador: 

Prof. Titular Stelio Pacca Loureiro Luna (Depto. Cirurgia e Anestesiologia Veterinária-

FMVZ/ UNESP/ Botucatu) 

Co-orientadora: 

Profa. Titular Fernanda da Cruz Landim (Depto. Reprodução e Radiologia Veterinária. 

FMVZ/ UNESP/ Botucatu) 
Equipe: 

Profa. Titular Sheila Canevese Rahal (Depto. Cirurgia e Anestesiologia Veterinária-FMVZ/ 

UNESP/ Botucatu) 

Dr. Leandro Maia (PG-Depto. Reprodução Animal-FMVZ/ UNESP/ Botucatu) 

Dr. Jean G. F. Joaquim (Depto. Cirurgia e Anestesiologia Veterinária-FMVZ/ UNESP/ Botucatu) 

M.V. Isadora Arruda  (PG-Depto. Reprodução Animal. FMVZ/ UNESP/ Botucatu)

M.V. Luciane dos Reis Mesquita (PG-Depto. Cirurgia e Anestesiologia Veterinária-FMVZ/

UNESP/ Botucatu)

Profa. Dra. Regina K. Takahira (Depto. Clínica Veterinária- FMVZ/ UNESP/ Botucatu)

M.V. Washington T. Kano (PG-Depto. Cirurgia e Anestesiologia Veterinária-FMVZ/ UNESP/

Botucatu)

M.V. Hugo S. Oliveira (Depto. Reprodução e Radiologia Veterinária-FMVZ/ UNESP/ Botucatu)



Celina Emiko Okamoto Okubo 

EFEITO ANALGÉSICO DO PLASMA RICO EM PLAQUETAS E CÉLULAS-

TRONCO NA DOR CRÔNICA DE CÃES COM DISPLASIA COXOFEMORAL 

Dissertação apresentada à Faculdade de Medicina Veterinária e Zootecnia, 

Universidade Estadual Paulista “Júlio de Mesquita Filho”, Campus de 

Botucatu, para obtenção do título de Mestre.  

__________________________________________ 

Orientador: Prof. Titular. Stelio Pacca Loureiro Luna 

Comissão Examinadora 

______________________________________ 
Profa. Titular Sheila Canavese Rahal 

Universidade Estadual Paulista 

______________________________________ 
Prof. Dr. Jean Guilherme Fernandes Joaquim 

Instituto Bioethicus – Botucatu-SP 

______________________________________ 
Profa. Dra. Fabiana Ferreira de Souza 

Universidade Estadual Paulista 

______________________________________ 
Profa. Dra. Bruna De Vita 

Pesquisadora 

Botucatu, 23 de Maio de 2016.



	
   	
  

	
  

	
  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DEDICATÓRIA 

  

À minha querida família, pela paciência e entendimento nos momentos de 

ausência. 

Ao meu caro e eterno mestre Prof. Stelio Pacca Loureiro Luna que sempre com 

muita sabedoria me recebe de braços abertos para iluminar meu caminho do 

conhecimento.  

 

“Conheça todas as teorias, domine todas as técnicas, mas ao tocar uma alma 

humana, seja apenas outra alma humana.” 

Carl Jung



	
   	
  

	
  

	
  

AGRADECIMENTOS 
 

 À sincronicidade da vida, que faz com que uma situação crie laços de 

amizade que duram uma vida toda. 

 Aos meus pais, que com muita luz e convicção, desde o início me 

ensinaram que o conhecimento abre portas inigualáveis. 

 Ao meu esposo Maurício e meu filho Leonardo que neste período 

conseguiram entender a necessidade de minha ausência pela busca 

incessante de meus objetivos. 

 Ao Prof. Stelio Pacca Loureiro Luna e à Profa. Maria Luísa Buffo de 

Cápua minha eterna gratidão e carinho por todo apoio, sabedoria e amizade. 

 Ao Prof. Jean Guilherme Fernandes Joaquim pelo ensinamento e 

exemplo incansável de buscar novas formas de ajudar nossos animais. 

 À Profa. Fernanda da Cruz Landim que com muita solicitude me permitiu 

uma vivência incrível no laboratório de cultivo celular. 

 À Profa. Sheila Canavese Rahal por ser minha eterna professora de 

ortopedia veterinária, e juntamente com a Luciane dos Reis Mesquita, permitiu 

que eu vivenciasse a experiência da avaliação baropodométrica. 

 Às minhas queridas companheiras, Danielle Barberini, Marianne 

Camargos, Luciane dos Reis e Isadora Arruda que fizeram este período em 

Botucatu ficar mais acolhedor e divertido.  

 A todo departamento de Radiologia Veterinária do Hospital Veterinário 

da FMVZ, principalmente ao meu colega de pós-graduação Hugo Salvador 

Oliveira, que permitiram a viabilidade dos exames radiográficos com muita 

prontidão.  

  A todos os amigos da FMVZ UNESP Botucatu que compartilharam 

comigo momentos difíceis e alegres nesta caminhada.  

 A todos os professores da FMVZ UNESP Botucatu que sempre me 

inspiraram a ser uma pessoa melhor e uma profissional mais dedicada. 

 Aos meus inesquecíveis Tchuky, Kelly, Fofinha, Lilica, Bob, Pitoco, Nala, 

e também a todos outros cachorros incríveis que tive a sorte de tê-los como 

meus professores e que fizeram com que eu amasse tanto minha carreira 

como médica veterinária. 



	
   	
  

	
  

	
  

LISTA DE ANEXOS 

Página 

ANEXO 1- Escala Analógica Visual (EAV) da dor (EAVdor) e Escala Analógica Visual 

(EAV) de claudicação (EAVloc)-----------------------------------------------------------------------32 

ANEXO 2 - Breve Inventário de dor canina (BIDC)--------------------------------------------- 33 

ANEXO 3 - Indicador de Dor Crônica da Universidade de Helsink  (IDCH)-------------- 34 

ANEXO 4 - Escala Numérica Descritiva (END)-------------------------------------------------- 35 

ANEXO 5 - Escala Analógica Visual (EAV) de dor à palpação (EAVpalp dor)---------- 36 

ANEXO 6 - Impressão geral do proprietário sobre a qualidade de vida do cão (IGP)- 36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



	
   	
  

	
  

	
  

LISTA DE ABREVIATURAS, SIGLAS E SÍMBOLOS 
 
  
p         Nível de significância 

?                      Desvio padrão 

BIDC        Breve Inventário de Dor Canina 

BVS         Biblioteca Virtual em Saúde 

CEUA        Comissão de Ética no Uso de Animais 

CT                   Célula-tronco 

CTM-TAs        Células-tronco mesenquimais derivadas de tecido adiposo 

DAD         Doença articular degenerativa 

DCF                Displasia coxofemoral 

DMSO             Dimetilsulfóxido 

DP         Distribuição do Peso 

EAV         Escala Analógica Visual 

EAVdor        Escala Analógica Visual para dor 

EAVloc        Escala Analógica Visual para claudicação 

END         Escala Numérica Descritiva 

FMVZ        Faculdade de Medicina Veterinária e Zootecnia 

Kg                   Quilogramas 

IDCH               Indicador de Dor Crônica da Universidade de Helsink   

IGP                 Impressão Geral do Proprietário sobre a qualidade de vida do 

cão 

µM                   Micrômetros 

mL                   Mililitros 

µL                    Microlitros 

n                      Número de animais  

PBS                 Solução Tampão Fosfato-salino 

PCR                 Reação em Cadeia pela Polimerase  

PDGF              Fator de Crescimento Derivado de Plaquetas 

PRP                 Plasma Rico em Plaquetas 

SFB                 Soro Fetal Bovino 

TGF-beta         Fator de Crescimento Transformador beta 

VEGF              Fator de Crescimento Vascular Endotelial



	
   	
  

	
  

	
  

 

SUMÁRIO 

 

Página 

RESUMO------------------------------------------------------------------------------------11 

ABSTRACT---------------------------------------------------------------------------------12 

CAPÍTULO I 

1.  Introdução-------------------------------------------------------------------------------14 

2. Revisão de literatura------------------------------------------------------------------14 

2.1 –Doença articular degenerativa (DAD) coxofemoral bilateral em 

cães---------------------------------------------------------------------------------------14 

2.2 -Células-Tronco Mesenquimais derivadas de tecido adiposo (CTM-

TAs)----------------------------------------------------------------------------------16 

2.3 -Plasma Rico em Plaquetas (PRP)------------------------------------------18 

3. Referências bibliográficas-----------------------------------------------------------21 

4. Anexos -----------------------------------------------------------------------------------32 

 

 CAPÍTULO II 

1.    Artigo Científico-----------------------------------------------------------------------38

 

 

 

 

 



	
  

	
  

 

RESUMO 

 

OKAMOTO-OKUBO, C.E. Efeito analgésico do plasma rico em plaquetas e 

células-tronco na dor crônica de cães com displasia coxofemoral. 2016. 

66p. Dissertação (Mestrado) - Faculdade de Medicina Veterinária e Zootecnia, 

Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, 2016. 

Este estudo clínico, controlado, aleatório, duplo cego, investigou o efeito intra-

articular do plasma rico em plaquetas (PRP) (n = 8) ou de células-tronco 

alogênicas (CT) (n = 8) na dor crônica de cães com displasia coxofemoral 

(DCF) bilateral. Os proprietários avaliaram o Breve Inventário de Dor Canina 

(BIDC), o Índice de Dor Crônica de Helsink (IDCH), a Escala Analógica Visual 

para dor (EAVdor) e claudicação (EAVloc), e a Qualidade de Vida (QV). Uma 

médica veterinária avaliou a Escala Visual Analógica da dor à palpação 

(EAVpalp), a Escala Numérica Descritiva para dor (END) e a porcentagem de 

distribuição de peso corporal. As avaliações foram realizadas antes, aos 30 e 

60 dias após o tratamento. Depois de CT, IDCH, EAVdor e EAVpalp foram 

reduzidos, QV aumentou aos 60 dias e BIDC reduziu aos 30 e 60 dias. Após 

PRP, EAVloc e END reduziram em 60 dias e BIDC aos 30 e 60 dias. Não 

houve diferença entre os grupos. Ambos CT e PRP foram aparentemente 

benéficos para reduzir a dor crônica em cães que sofrem de DCF bilateral por 

60 dias, mas CT foi superior nas variáveis de dor crônica em comparação com 

PRP. O benefício clínico de ambos os tratamentos é que eles produzem um 

alívio da dor a longo prazo em cães com DCF sem efeitos adversos aparentes. 

 

Palavras chave: Células-tronco, injeções, intra-articular, coxofemoral, cães 



	
   	
  

	
  

	
  

ABSTRACT 

 

Analgesic effect of platelet-rich plasma and stem cells in chronic pain in 

dogs with hip dysplasia. 2016. 66p. Faculdade de Medicina Veterinária e 

Zootecnia, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, 

2015. 

This randomized, controlled, double-blind clinical study investigated the effect of 

intra-articular platelet-rich plasma (PRP) (n=8) or allogeneic stem cells (SC) 

(n=8) in chronic pain of dogs with bilateral hip dysplasia (HD). The owners 

evaluated the Canine Brief Pain Inventory (CBPI), the Helsinki Chronic Pain 

Index (HCPI), a Visual Analogue Scale for pain (VASpain) and lamness 

(VASloc) and the quality of life (QL). A veterinarian evaluated the Visual 

Analogue Scale of pain in response to palpation (VASpalp), the descriptive 

numerical scale for pain (DNS) and the percentage of body weight distribution. 

All evaluations were performed before, at 30 and 60 days after treatment. After 

SC, HCPI, VASpain and VASpalp reduced and QL increased at 60 days and 

CBPI reduced at 30 and 60 days. After PRP, VASloc and DNS reduced at 60 

days and CBPI at 30 and 60 days. There was no difference between groups. 

Both SCs and PRP were apparently beneficial to reduce chronic pain in dogs 

suffering from bilateral hip dysplasia for 60 days, but SCs improved more 

chronic pain variables compared to PRP. The clinical benefit of both treatments 

is that they produce a long term pain relief in dogs with hip dysplasia with no 

apparent adverse effects. 

Key words: Stem cells, injections, intra-articular, hip joint, dogs



	
   	
  

	
  

	
  

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO  I

 

 

 

 

 

 

 

 

 

 

 

 



	
  

14	
  	
  

1. INTRODUÇÃO  

A medicina regenerativa é uma nova área das medicinas humana e 

veterinária e é foco de estudos recentes, principalmente voltados para o uso da 

terapia de células-tronco mesenquimais derivadas de tecido adiposo (CTM-

TAs), com o objetivo de tratar osteoartroses 1-20. Com esse mesmo foco, a 

aplicação de Plasma Rico em Plaquetas (PRP) também é amplamente utilizada 

para tratar problemas osteoarticulares não apenas no homem, mas também 

em diversas espécies como nos cães 7,8,21-33. 

A dispasia coxofemoral (DCF) é uma alteração não infecciosa e 

progressiva que ocorre na cartilagem das articulações acometidas34. 

Caracteriza-se por uma sinovite e degeneração da cartilagem articular com 

perda da matriz, e que pode resultar na completa perda da superfície 

cartilaginosa35.  

 A hipótese deste estudo é que as terapias com CTM-TAs alogênicas ou 

PRP são alternativas terapêuticas eficazes e similares para controlar a dor e 

melhorar a qualidade de vida em cães com DCF bilateral 3,4. 

 

2. REVISÃO DE LITERATURA 

 

   2.1- Displasia coxofemoral (DCF) bilateral em cães 

A displasia coxofemoral (DCF) é uma enfermidade crônica, conhecida 

também como doença articular degenerativa (DAD)36. Estudos mostram a alta 

prevalência da DAD em cães, com 20% da população canina acima de 1 ano 

de idade apresentando esta enfermidade em diferentes graus37. A DCF está 

relacionada com dor crônica, claudicação, incapacidade funcional e redução da 



	
   	
  

	
  

	
  

21	
  

3- REFERÊNCIAS BIBLIOGRÁFICAS 
 
 (Segundo normas Vancouver) 
 

1. Guercio A, Marco PD, Casella S, et al. Production of canine 

mesenchymal stem cells from adipose tissue and their application in dogs with 

chronic osteoarthritis of the humeroradial joints. Cell Bio Int. 2012;36:189–194. 

2. Black LL, Gaynor J, Gahring D, et al. Effect of adipose-derived 

mesenchymal stem and regenerative cells on lameness in dogs with chronic 

osteoarthritis of the coxofemoral joints: a randomized, double-blinded, 

multicenter, controlled trial. Vet Ther. 2007;4:272-284. 

3. Black  LL, Gaynor J, Adams C, et al. Effect of intraarticular injection of 

autologous adipose-derived mesenchymal stem and regenerative cells on 

clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. 

2008;9:192-200. 

4. Cuervo B, Rubio M, Sopena J, et al. Hip Osteoarthritis in Dogs: A 

Randomized Study Using Mesenchymal Stem Cells from Adipose Tissue and 

Plasma Rich in Growth Factors. Int J Mol Sci. 2014;15:13437-13460. 

5. Vilar JM, Batista M, Morales M, et al. Assessment of the effect of 

intraarticular injection of autologous adipose-derived mesenchymal stem cells in 

osteoarthritic dogs using a double blinded force platform analysis. BMC Vet 

Res. 2014;10. 

6. Vilar JM, Morales M, Santana A, et al. Controlled, blinded force platform 

analysis of the effect of intraarticular injection of autologous adipose-derived 

mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. 

BMC Vet Res. 2013;9. 



	
  

22	
  	
  

7. Upchurch DA. Administration of adipose-derived stromal vascular 

fraction and platelet rich plasma in dogs with coxofemoral osteoarthritis. 

Department of Clinical Sciences. 2015. 

8. Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and 

platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis 

in Beagle dogs. J Orthop Surg Res. 2016;11:9. 

9. Uth K, Trifonov D. Stem cell application for osteoarthritis in the knee 

joint: A minireview. World J Stem Cells. 2014;6:629-636. 

10. Tsai S-Y, Huang Y-C, Chueh L-L, et al. Intra-articular transplantation of 

porcine adipose-derived stem cells for the treatment of canine osteoarthritis: A 

pilot study. World J Transplant. 2014;4:196-205. 

11. Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the 

treatment of traumatic articular cartilage defects: a comprehensive review. 

Arthritis Res Ther. 2014;16. 

12. Lee JK, Responte DJ, Cissell DD, et al. Clinical translation of stem cells: 

insight for cartilage therapies. Crit Rev Biotechnol 2014;34:89–100. 

13. Wood JA, Chung D-J, Park SA, et al. Periocular and Intra-Articular 

Injection of Canine Adipose-Derived Mesenchymal Stem Cells: An In Vivo 

Imaging and Migration Study. J Ocul Pharmacol Ther. 2012;28. 

14. Kim I, Bang SI, Lee SK, et al. Clinical implication of allogenic 

implantation of adipogenic differentiated adipose-derived stem cells. Stem Cells 

Transl Med. 2014;3:1312-1321. 

15. Shen W, Chen J, Zhu I, et al. Intra-Articular Injection of Human Meniscus 

Stem/Progenitor Cells Promotes Meniscus Regeneration and Ameliorates 



	
  

23	
  	
  

Osteoarthritis Through Stromal Cell-Derived Factor-1/CXCR4- Mediated 

Homing. Stem Cells Transl Med. 2014;3:387–394. 

16. Qi Y, Feng G, Yan W. Mesenchymal stem cell-based treatment for 

cartilage defects in osteoarthritis. Mol Biol Rep. 2012;39:5683–5689. 

17. Whitworth DJ, Banks TA. Stem cell therapies for treating osteoarthritis: 

Prescient or premature? Vet J. 2014;202:416–424. 

18. Shenaq DS, Rastegar F, Petkovic D, et al. Mesenchymal progenitor cells 

and their orthopedic applications: Forging a Path towards Clinical Trials. Stem 

Cells Int. 2010. 

19. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. 

Arthritis Res Ther. 2008;10. 

20. Carrade DD, Owens SD, Galuppo LD, et al. Clinicopathologic findings 

following intra-articular injection of autologous and allogeneic placentally 

derived equine mesenchymal stem cells in horses. Cytotherapy. 2011;13:419-

430. 

21. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection 

grafts for musculoskeletal injuries: a review. Curr Rev Musculoskeletal Med. 

2008;1:165-174. 

22. Drengk A, Zapf A, Sturmer EK, et al. Influence of platelet-rich plasma on 

chondrogenic differentiation and proliferation of chondrocytes and 

mesenchymal stem cells. Cells Tissues Organs. 2009;189:317-326. 

23. Aziz Aly LA, El-Menoufy H, Hassan A, et al. Influence of autologus 

adipose derived stem cells and PRP on regeneration of dehiscence-type 

defects in alveolar bone: A Comparative Histochemical and Histomorphometric 

Study in Dogs. Int J Stem Cells. 2011;4:61-69. 



	
  

24	
  	
  

24. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee 

injections for the treatment of degenerative cartilage lesions and osteoarthritis. 

Knee Surg Sports Traumatol Arthrosc. 2011;19:528-535. 

25. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in 

musculoskeletal science. JRSM Short Rep. 2012;3:40. 

26. Mishra A, Harmon K, Woodall J, et al. Sports medicine applications of 

platelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185-1195. 

27. Mishra A, Randelli P, Barr C, et al. Platelet-rich plasma and the upper 

extremity. Hand Clin. 2012;28:481-491. 

28. Zarins B. Platelet-rich plasma (PRP) – Potential orthopaedic applications 

of autologous preparations rich in growth factors (PRGF). Massachusetts 

General Hospital, 2013. 

29. Hoareau GL, Jandrey KE, Burges J, et al. Comparison of the platelet-rich 

plasma and buffy coat protocols for preparation of canine platelet concentrates. 

Vet Clin Pathol. 2014;43:513-518. 

30. Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix 

restorative mechanisms of platelet-rich plasma in osteoarthritis.  Am J Sports 

Med. 2014;42:35-41. 

31. Cook JL, Smith PA, Bozynski CC, et al. Multiple injections of 

leukoreduced platelet rich plasma reduce pain and functional impairment in a 

canine model of ACL and meniscal deficiency. J Orthop Res. 2015; 34:607-

6015. 

32. Kazemi D, Fakhrjou A. Leukocyte and Platelet Rich Plasma (L-PRP) 

Versus Leukocyte and Platelet Rich Fibrin (L-PRF) For Articular Cartilage 



	
  

25	
  	
  

Repair of the Knee: A Comparative Evaluation in an Animal Model. Iran Red 

Crescent Med J. 2015;17:e19594. 

33. Xie X, Ulici V, Alexander PG, et al. Platelet-Rich Plasma Inhibits 

Mechanically Induced Injury in Chondrocytes. Arthroscopy. 2015;31:1142-1150. 

34. Wiegant K, Intema F, van Roermund PM, et al. Evidence of cartilage 

repair by joint distraction in a canine model of osteoarthritis. Arthritis 

Rheumatol. 2015;67:465-474. 

35. Lust G, Summers BA. Early, asymptomatic stage of degenerative joint 

disease in canine hip joints. Am J Vet Res. 1981;42:1849-1855. 

36. Boal S, Miguel Carreira L. Serum and synovial fluid C-reactive protein 

level variations in dogs with degenerative joint disease and their relationships 

with physiological parameters. Vet Res Commun. 2015;39:163-169. 

37. Paster ER, LaFond E, Biery DN, et al. Estimates of prevalence of hip 

dysplasia in Golden Retrievers and Rottweilers and the influence of bias on 

published prevalence figures. J Am Vet Med Assoc. 2005;226:387-392. 

38. Henrotin Y, Sanchez C, Balligand M. Pharmaceutical and nutraceutical 

management of canine osteoarthritis: present and future perspectives. Vet J. 

2005;170:113-123. 

39. Flückiger M. Scoring radiographs for canine Hip Dysplasia - The big 

three organisations in the world. European Journal Compagnion Animal 

Practice. 2007;17:135-140. 

40. Brandt KD, Dieppe P, Radin E. Etiopathogenesis of osteoarthritis. Med 

Clin North Am. 2009;93:1-24, xv. 

41. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex 

process that involves the entire joint. J Med Life. 2014;7:37-41. 



	
  

26	
  	
  

42. Brown DC, Boston RC, Coyne JC, et al. Ability of the canine brief pain 

inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet 

Med Assoc. 2008;233:1278-1283. 

43. Alexander JW. The pathogenesis of canine hip dysplasia. Vet Clin North 

Am: Small Anim Pract. 1992;22:503-511. 

44. Malek S, Sample SJ, Schwartz Z, et al. Effect of analgesic therapy on 

clinical outcome measures in a randomized controlled trial using client-owned 

dogs with hip osteoarthritis. BMC Vet Res. 2012;8:185. 

45. Perea S. Nutritional management of osteoarthritis. Compendium on 

Continuing Education for the Practising Veterinarian. 2012;34:E4. 

46. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with 

relevance for clinical practice.The Lancet. 2011;377:2115-2126. 

47. Teixeira LR. Owner assessment of chronic pain and gait analysis of dogs 

with hip dysplasia treated with acupuncture. Botucatu Medical School. Botucatu 

-SP: São Paulo State University, 2015. 

48. Holton LL, Scott EM, Nolan AM, et al. Comparison of three methods 

used for assessment of pain in dogs. J Am Vet Med Assoc. 1998;212:61-66. 

49. Brown DC, Boston RC, Coyne JC, et al. Development and psychometric 

testing of an instrument designed to measure chronic pain in dogs with 

osteoarthritis. Am J Vet Res. 2007;68:631-637. 

50. Anderson AF, Smith M. Progress in cartilage restoration. Am J Sports 

Med. 2009;37 Suppl 1:7S-9S. 

51. Smyth NA, Murawski CD, Haleem AM, et al. Establishing proof of 

concept: Platelet-rich plasma and bone marrow aspirate concentrate may 



	
  

27	
  	
  

improve cartilage repair following surgical treatment for osteochondral lesions of 

the talus. World J Orthop. 2012;3:101-108. 

52. Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical 

trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. 

2007;230:514-521. 

53. Innes J. Diet and disease: exploring the link through nutrigenomics. Can 

Vet J. 2006;47:68-70. 

54. Pereira LdV. A importância do uso das células tronco para a saúde 

pública. Ciência &amp;amp; Saúde Coletiva. 2008;13:7-14. 

55. Haas S, Weidner N, Winkler Jr. Adult stem cell therapy in stroke. Curr 

Opin Neurol. 2005;18:59-64. 

56. Carrade DD, Borjesson DL. Immunomodulation by Mesenchymal Stem 

Cells in Veterinary Species. Comp Med. 2013;63:207–217. 

57. Raghunath J, Salacinski HJ, Sales KM, et al. Advancing cartilage tissue 

engineering: the application of stem cell technology. Curr Opin  Biotechnol. 

2005;16:503-509. 

58. Oldershaw RA. Cell sources for the regeneration of articular cartilage: 

the past, the horizon and the future. Int J Exp Pathol. 2012;93:389-400. 

59. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated 

source of stem cells for biotechnology. Trends Biotechnol. 2006;24:150-154. 

60. Grasys J, Kim BS, Pallua N. Content of Soluble Factors and 

Characteristics of Stromal Vascular Fraction Cells in Lipoaspirates from 

Different Subcutaneous Adipose Tissue Depots. Aesthet Surg J. 2016. 

61. Church CD, Berry R, Rodeheffer MS. Isolation and study of adipocyte 

precursors. Methods Enzymol. 2014;537:31-46. 



	
  

28	
  	
  

62. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of 

inflammation. Annu Rev Pathol. 2011;6:457-478. 

63. Zhang J, Huang X, Wang H, et al. The challenges and promises of 

allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell 

Res Ther. 2015;6:234. 

64. Mrugala D, Bony C, Neves N, et al. Phenotypic and functional 

characterisation of ovine mesenchymal stem cells: application to a cartilage 

defect model. Ann Rheum Dis. 2008;67:288-295. 

65. Carrade DD, Lame MW, Kent MS, et al. Comparative Analysis of the 

Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem 

Cells. Cell Med. 2012;4:1-11. 

66. Poncelet AJ, Vercruysse J, Saliez A, et al. Although pig allogeneic 

mesenchymal stem cells are not immunogenic in vitro, intracardiac injection 

elicits an immune response in vivo. Transplant Res. 2007;83:783-790. 

67. Zhang J, Bai X, Zhao B, et al. Allogeneic adipose-derived stem cells 

promote survival of fat grafts in immunocompetent diabetic rats. Cell  Tissue 

Res. 2015. 

68. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells 

suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. 

Exp Hematol. 2002;30:42-48. 

69. Berman DM, Willman MA, Han D, et al. Mesenchymal stem cells 

enhance allogeneic islet engraftment in nonhuman primates. Diabetes. 

2010;59:2558-2568. 



	
  

29	
  	
  

70. Kang JW, Kang KS, Koo HC, et al. Soluble factors-mediated 

immunomodulatory effects of canine adipose tissue-derived mesenchymal stem 

cells. Stem Cells Dev. 2008;17:681-693. 

71. Kim HS, Kim KH, Kim SH, et al. Immunomodulatory effect of canine 

periodontal ligament stem cells on allogenic and xenogenic peripheral blood 

mononuclear cells. J Periodontal Implant Sci.  2010;40:265-270. 

72. Lee WS, Suzuki Y, Graves SS, et al. Canine bone marrow-derived 

mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in 

vitro but fail to enhance engraftment in canine bone marrow transplantation. 

Biol Blood Marrow Transplant. 2011;17:465-475. 

73. Khatri M, O'Brien TD, Sharma JM. Isolation and differentiation of chicken 

mesenchymal stem cells from bone marrow. Stem Cells Dev. 2009;18:1485-

1492. 

74. Moreno R, Martinez-Gonzalez I, Rosal M, et al. Characterization of 

mesenchymal stem cells isolated from the rabbit fetal liver. Stem Cells Dev. 

2010;19:1579-1588. 

75. Liu H, Kemeny DM, Heng BC, et al. The immunogenicity and 

immunomodulatory function of osteogenic cells differentiated from 

mesenchymal stem cells. J Immunol. 2006;176:2864-2871. 

76. Cho PS, Messina DJ, Hirsh EL, et al. Immunogenicity of umbilical cord 

tissue derived cells. Blood. 2008;111:430-438. 

77. Peroni JF, Borjesson DL. Anti-inflammatory and immunomodulatory 

activities of stem cells. Vet Clin North Am: Equine Pract. 2011;27:351-362. 

78. Le Blanc K, Rasmusson I, Gotherstrom C, et al. Mesenchymal stem cells 

inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on 



	
  

30	
  	
  

phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307-

315. 

79. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal Stromal Cells. Ann  

N Y Acad Sci. 2009;1176:101–117. 

80. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in 

musculoskeletal science. JRSM Short  Rep. 2012;3. 

81. Carneiro MO, Barbieri CuH, Neto JB. Platelet-Rich Plasma gel promotes 

regeneration of articular cartilage in knees of sheeps. Acta Ortop Bras. 2013;21. 

82. Perazzi A, Busetto R, Martinello T, et al. Description of a double 

centrifugation tube method for concentrating canine platelets. BMC Vet Res. 

2013;9. 

83. Aleixo GAS, Coelho MCOC, Teixeira MN, et al. Comparação entre dois 

protocolos para obtenção de plasma rico em plaquetas, em cães. Arq Bras Med 

Vet Zootec. 2011;63:567-573. 

84. Thoesen MS, Berg-Foels WS, Stokol T, et al. Use of a centrifugation-

based, point-of-care device for production of canine autologous bone marrow 

and platelet concentrates. Am J Vet Res. 2006;67:1655-1661. 

85. Trichler SA, Bulla SC, Thomason J, et al. Ultra-pure platelet isolation 

from canine whole blood. BMC Vet Res. 2013;9:144. 

86. Dohan Ehrenfest DM, Bielecki T, Mishra A, et al. In search of a 

consensus terminology in the field of platelet concentrates for surgical use: 

platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization 

and leukocytes. Curr Pharm Biotechnol. 2012;13:1131-1137. 

87. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors 

enhance the secretion of hyaluronic acid and induce hepatocyte growth factor 



	
  

31	
  	
  

production by synovial fibroblasts from arthritic patients In: M S, ed: 

Rheumatology. 2007;1769–1772. 

88. Brossi PM, Moreira JJ, Machado TsS, et al. Platelet-rich plasma in 

orthopedic therapy: a comparative systematic review of clinical and 

experimental data in equine and human musculoskeletal lesions. BMC Vet Res. 

2015;11. 

89. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of 

proteins for healing and tissue regeneration. J Thromb  Haemostasis. 

2004;91:4-15. 

90. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine 

articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis 

Cartilage. 2006;14:1272-1280. 

91. Van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate 

inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports 

Med. 2011;39:2362-2370. 

92. Wei L-C, Gao S-G, Xu M, et al. A novel hypothesis: The application of 

platelet-rich plasma can promote the clinical healing of white-white meniscal 

tears. Med Sci Monit. 2012;8:HY47-50. 

93. Bozynski CC, Stannard JP, Smith P, et al. Acute Management of 

Anterior Cruciate Ligament Injuries Using Novel Canine Models. J  Knee Surg. 

2015.  

 

 

 

	
  



	
  

	
  

61	
  

5.  CONCLUSION 

 

 Both SCs and PRP were apparently beneficial to reduce chronic pain in 

dogs suffering from bilateral hip dysplasia for 60 days, but SCs improved most 

of chronic pain variables compared to PRP. The clinical benefit of both 

treatments is that they produce a long term pain relief in dogs with hip 

dysplasia, with no apparent adverse effects. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



	
  

	
  

62	
  

6.  REFERENCES 	
  

	
  (Vancouver	
  Citation	
  Style)	
  

 

1. Mortellaro CM. Pathophysiology of osteoarthritis. Vet Res Comm. 

2003;27 Suppl 1:75-78. 

2. Carneiro MO, Barbieri CuH, Neto JB. Platelet-Rich Plasma gel promotes 

regeneration of articular cartilage in knees of sheeps. Acta Ortop Bras. 2013;21. 

3. Vilar JM, Morales M, Santana A, et al. Controlled, blinded force platform 

analysis of the effect of intraarticular injection of autologous adipose-derived 

mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. 

BMC Vet Res. 2013;9. 

4. Black  LL, Gaynor J, Adams C, et al. Effect of intraarticular injection of 

autologous adipose-derived mesenchymal stem and regenerative cells on 

clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. 

2008;9:192-200. 

5. Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and 

platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis 

in Beagle dogs. J Orthop Surg Res. 2016;11:9. 

6. Upchurch DA. Administration of adipose-derived stromal vascular 

fraction and platelet rich plasma in dogs with coxofemoral osteoarthritis. 

Department of Clinical Sciences, 2015. 

7. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors 

enhance the secretion of hyaluronic acid and induce hepatocyte growth factor 

production by synovial fibroblasts from arthritic patients. Rheumatology. 

2007;46:1769-1772. 



	
  

	
  

63	
  

8. Cuervo B, Rubio M, Sopena J, et al. Hip Osteoarthritis in Dogs: A 

Randomized Study Using Mesenchymal Stem Cells from Adipose Tissue and 

Plasma Rich in Growth Factors. Int J Mol Sci. 2014;15:13437-13460. 

9. Guercio A, Marco PD, Casella S, et al. Production of canine 

mesenchymal stem cells from adipose tissue and their application in dogs with 

chronic osteoarthritis of the humeroradial joints. Cell Biol Int. 2012;36:189–194. 

10. Black LL, Gaynor J, Gahring D, et al. Effect of adipose-derived 

mesenchymal stem and regenerative cells on lameness in dogs with chronic 

osteoarthritis of the coxofemoral joints: a randomized, double-blinded, 

multicenter, controlled trial. Vet Ther. 2007;4:272-284. 

11. Vilar JM, Batista M, Morales M, et al. Assessment of the effect of 

intraarticular injection of autologous adipose-derived mesenchymal stem cells in 

osteoarthritic dogs using a double blinded force platform analysis. BMC Vet 

Res. 2014;10. 

12. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in 

musculoskeletal science.JRSM Short Rep. 2012;3. 

13. Hoareau GL, Jandrey KE, Burges J, et al. Comparison of the platelet-rich 

plasma and buffy coat protocols for preparation of canine platelet concentrates. 

Vet Clin Pathol. 2014;43:513-518. 

14. Aleixo GAS, Coelho MCOC, Teixeira MN, et al. Comparação entre dois 

protocolos para obtenção de plasma rico em plaquetas, em cães. Arq Bras  

Med Vet Zootec. 2011;63:567-573. 

15. Dohan Ehrenfest DM, Bielecki T, Mishra A, et al. In search of a 

consensus terminology in the field of platelet concentrates for surgical use: 



	
  

	
  

64	
  

platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization 

and leukocytes. Curr Pharm Biotechnol. 2012;13:1131-1137. 

16. Brossi PM, Moreira JJ, Machado TsS, et al. Platelet-rich plasma in 

orthopedic therapy: a comparative systematic review of clinical and 

experimental data in equine and human musculoskeletal lesions. BMC Vet Res. 

2015;11. 

17. Perazzi A, Busetto R, Martinello T, et al. Description of a double 

centrifugation tube method for concentrating canine platelets. BMC Vet Res. 

2013;9. 

18. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of 

proteins for healing and tissue regeneration. Thromb Haemostasis. 2004;91:4-

15. 

19. Flückiger M. Scoring radiographs for canine Hip Dysplasia - The big 

three organisations in the world. EJCAP. 2007;17. 

20. Brown DC, Boston RC, Coyne JC, et al. Development and psychometric 

testing of an instrument designed to measure chronic pain in dogs with 

osteoarthritis. Am J Vet Res. 2007;68:631-637. 

21. Hielm-Björkman AK, Rita H, Tulamo R-M. Psychometric testing of the 

Helsinki chronic pain index by completion of a questionnaire in Finnish by 

owners of dogs with chronic signs of pain caused by osteoarthritis. Am J Vet 

Res. 2009;70:727-734. 

22. Holton LL, Scott EM, Nolan AM, et al. Comparison of three methods 

used for assessment of pain in dogs. J Am Vet Med Assoc. 1998;212:61-66. 



	
  

	
  

65	
  

23. Teixeira LR. Owner assessment of chronic pain and gait analysis of dogs 

with hip dysplasia treated with acupuncture. Botucatu Medical School. Botucatu 

-SP: São Paulo State University, 2015. 

24. Mokbel AN, Tookhy OSE, Shamaa AA, et al. Homing and reparative 

effect of intra-articular injection of autologus mesenchymal stem cells in 

osteoarthritic animal model. BMC Musculoskelet Disord. 2011;12. 

25. Kazemi D, Fakhrjou A. Leukocyte and Platelet Rich Plasma (L-PRP) 

Versus Leukocyte and Platelet Rich Fibrin (L-PRF) For Articular Cartilage 

Repair of the Knee: A Comparative Evaluation in an Animal Model. Iran Red 

Crescent Med J. 2015;17:e19594. 

26. Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix 

restorative mechanisms of platelet-rich plasma in osteoarthritis.  Am J  Sports 

Med. 2014;42:35-41. 

27. Arnoczky SP, Torzilli PA. Biomechanical analysis of forces acting about 

the canine hip. Am J Vet Res. 1981;42:1581-1981. 

28. Luna SP, Basilio AC, Steagall PV, et al. Evaluation of adverse effects of 

long-term oral administration of carprofen, etodolac, flunixin meglumine, 

ketoprofen, and meloxicam in dogs. Am J Vet Res. 2007;68:258-264. 

29. Malek S, Sample SJ, Schwartz Z, et al. Effect of analgesic therapy on 

clinical outcome measures in a randomized controlled trial using client-owned 

dogs with hip osteoarthritis. BMC Vet Res. 2012;8:185. 

30. KuKanich B. Outpatient oral analgesics in dogs and cats beyond 

nonsteroidal antiinflammatory drugs: an evidence-based approach. Vet Clin  

North Am Small Anim Pract. 2013;43:1109-1125. 



	
  

	
  

66	
  

31. Lascelles BD, Gaynor JS, Smith ES, et al. Amantadine in a multimodal 

analgesic regimen for alleviation of refractory osteoarthritis pain in dogs. J Vet 

Intern Med. 2008;22:53-59. 

32. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal Stromal Cells. Ann N 

Y Acad Sci. 2009;1176:101–117. 

33. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors 

enhance the secretion of hyaluronic acid and induce hepatocyte growth factor 

production by synovial fibroblasts from arthritic patients. Rheumatology. 

2007;1769–1772. 

34. Jaeger GT, Larsen S, Soli N, et al. Two years follow-up study of the pain-

relieving effect of gold bead implantation in dogs with hip-joint arthritis. Acta Vet 

Scand. 2007;49:9. 

35. Mills K, Hettinga BA, Pohl MB, et al. Between-limb kinematic asymmetry 

during gait in unilateral and bilateral mild to moderate knee osteoarthritis. Arch 

Phys Med Rehabil. 2013;94:2241-2247. 

36. Genevois JP, Chanoit G, Carozzo C, et al. Influence of anaesthesia on 

canine hip dysplasia score. J Vet Med Physiol Pathol Clin Med. 2006;53:415-

417. 

	
  




</field>
	</doc>
</add>